1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Hospital Acquired Disease Testing Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Indication
5.5 Market Breakup by Region
5.6 Market Forecast
5.7 SWOT Analysis
5.7.1 Overview
5.7.2 Strengths
5.7.3 Weaknesses
5.7.4 Opportunities
5.7.5 Threats
5.8 Value Chain Analysis
5.9 Porters Five Forces Analysis
5.9.1 Overview
5.9.2 Bargaining Power of Buyers
5.9.3 Bargaining Power of Suppliers
5.9.4 Degree of Competition
5.9.5 Threat of New Entrants
5.9.6 Threat of Substitutes
5.10 Price Analysis
6 Market Breakup by Indication
6.1 UTI (Urinary Tract Infection)
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 SSI (Surgical Site Infection)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Pneumonia
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Bloodstream Infections
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 MRSA (Methicillin-Resistant Staphylococcus Aureus)
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast
7 Market Breakup by Region
7.1 North America
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Europe
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Asia Pacific
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Middle East and Africa
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Latin America
7.5.1 Market Trends
7.5.2 Market Forecast
8 Competitive Landscape
8.1 Market Structure
8.2 Key Players
8.3 Profiles of Key Players
8.3.1 Abbott Laboratories
8.3.2 Alere, Inc.
8.3.3 Becton, Dickinson and Company
8.3.4 bioMérieux SA
8.3.5 F. Hoffmann-La Roche Ltd.
8.3.6 Hologic, Inc.
8.3.7 QIAGEN
8.3.8 Siemens Healthcare
8.3.9 Diatherix Laboratories, Inc.
8.3.10 Meridian Bioscience, Inc.
8.3.11 Thermo Fisher Scientific, Inc. (Life Technologies Corporation)
8.3.12 Cepheid, Inc.
List of Figures
Figure 1: Global: Hospital Acquired Disease Testing Market: Major Drivers and Challenges
Figure 2: Global: Hospital Acquired Disease Testing Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Hospital Acquired Disease Testing Market: Breakup by Indication (in %), 2024
Figure 4: Global: Hospital Acquired Disease Testing Market: Breakup by Region (in %), 2024
Figure 5: Global: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 6: Global: Hospital Acquired Disease Testing Industry: SWOT Analysis
Figure 7: Global: Hospital Acquired Disease Testing Industry: Value Chain Analysis
Figure 8: Global: Hospital Acquired Disease Testing Industry: Porter’s Five Forces Analysis
Figure 9: Global: Hospital Acquired Disease Testing (Urinary Tract Infection) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Hospital Acquired Disease Testing (Urinary Tract Infection) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Hospital Acquired Disease Testing (Surgical Site Infection) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Hospital Acquired Disease Testing (Surgical Site Infection) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Hospital Acquired Disease Testing (Pneumonia) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Hospital Acquired Disease Testing (Pneumonia) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Hospital Acquired Disease Testing (Bloodstream Infections) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Hospital Acquired Disease Testing (Bloodstream Infections) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Hospital Acquired Disease Testing (Methicillin-Resistant Staphylococcus Aureus) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Hospital Acquired Disease Testing (Methicillin-Resistant Staphylococcus Aureus) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Hospital Acquired Disease Testing (Other Indications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Hospital Acquired Disease Testing (Other Indications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: North America: Hospital Acquired Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: North America: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Europe: Hospital Acquired Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Europe: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Asia Pacific: Hospital Acquired Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Asia Pacific: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Middle East and Africa: Hospital Acquired Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Middle East and Africa: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Latin America: Hospital Acquired Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Latin America: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
List of Tables
Table 1: Global: Hospital Acquired Disease Testing Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Hospital Acquired Disease Testing Market Forecast: Breakup by Indication (in Million USD), 2025-2033
Table 3: Global: Hospital Acquired Disease Testing Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 4: Global: Hospital Acquired Disease Testing Market: Competitive Structure
Table 5: Global: Hospital Acquired Disease Testing Market: Key Players